Karel Allegaert1,2,3, Catherine Sherwin4,5. 1. Intensive Care and Department of Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands. allegaertkarel@hotmail.com. 2. Department of Development and Regeneration, KU, Leuven, Belgium. allegaertkarel@hotmail.com. 3. Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. allegaertkarel@hotmail.com. 4. Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA. 5. Clinical Trials Office, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Authors: Matthew W Linakis; Jessica K Roberts; Anita C Lala; Michael G Spigarelli; Natalie J Medlicott; David M Reith; Robert M Ward; Catherine M T Sherwin Journal: Clin Pharmacokinet Date: 2016-02 Impact factor: 6.447
Authors: Wei Du; Victoria Tutag Lehr; Mary Lieh-Lai; Winston Koo; Robert M Ward; Michael J Rieder; John N Van Den Anker; Jaxk H Reeves; Merene Mathew; Mirjana Lulic-Botica; Jacob V Aranda Journal: J Clin Pharmacol Date: 2013-01-24 Impact factor: 3.126